[1]DANIEL,PETEK,DIDIER,et al.Osteonecrosis of the femoral head:pathophysiology and current concepts of treatment[J].EFORT open reviews,2019,4(3):85-97.
[2]ANNA COHEN-ROSENBLUM,CUI QUANJUN.Osteonecrosis of the Femoral Head[J].The Orthopedic clinics of North America,2019,50(2):139-149.
[3]中华医学会骨科学分会关节外科学组股骨头坏死诊疗指南(2018年版)[J].中华骨科杂志,2018,38(12):705-715.
[4]ZHAO DW,YU M,HU K,et al.Prevalence of Nontraumatic Osteonecrosis of the Femoral Head and its Associated Risk Factors in the Chinese Population:Results from a Nationally Representative Survey[J].Chinese medical journal,2015,128(21):2843-2850.
[5]CHEN GM,XIE YY,LIU YY,et al.Taohong Siwu decoction for femoral head necrosis:A protocol for systematic review[J].Medicine (Baltimore),2020,99(13):e19368.
[6]王馨苑,黄夏冰,李娟,等.桃红四物汤“异病同治”类风湿性关节炎和骨关节炎的网络药理学及分子对接分析[J].中国组织工程研究,2022,26(15):2419-2425.
[7]白子兴,曹旭含,孙承颐,等.基于网络药理学探讨桃红四物汤延缓股骨头坏死病变进程作用机制[J].辽宁中医药大学学报,2020,22(12):65-70.
[8]王伟军,杨傲飞,汪伟,等.桃红四物汤对急性软组织损伤大鼠的保护作用及机制研究[J].中国中西医结合杂志,2022,42(10):1207-1212.
[9]申震,朱付平,刘天举,等.桃红四物液对大鼠肢体缺血-再灌注损伤炎症因子表达的影响研究[J].中华中医药学刊,2018,36(2):374-377.
[10]范卫闯,吕立桃,白登彦,等.桃红四物汤对类风湿关节炎模型大鼠关节肿胀改善效果及机制研究[J].新中医,2023,55(1):53-57.
[11]TANG DG,CONTI CJ.Endothelial cell development vasculogenesis angiogenesis and tumor neovascularization an update[J].Semin Thromb Hemost,2004,30(1):109-17.
[12]王小斌,蒋红心,屈长宏,等.桃红四物汤干预外周血内皮祖细胞数量与功能增加的时间剂量效应[J].中国组织工程研究,2019,23(9):1354-1358.
[13]陈旭东,陈伟豪,刘天浩,等.桃红四物汤对自发性高血压大鼠主动脉舒张功能的影响和内皮细胞的保护作用[J].时珍国医国药,2021,32(4):785-789.
[14]TANG Z,LI W,XIE H,et al.Taohong Siwu Decoction Promotes Osteo-Angiogenesis in Fractures by Regulating the HIF-1α Signaling Pathway[J].Evidence-based complementary and alternative medicine,2022,2022:6777447.
[15]冯海波.从外泌体MiR-126-VEGF/Notch信号轴探究桃红四物汤对创伤性ANFH大鼠血管新生的分子机制[D].长沙:湖南中医药大学,2022.
[16]HATHCOCK JJ.Flow effects on coagulation and thrombosis[J].Arteriosclerosis,Thrombosis and Vascular Biology,2006,26(8):1729-1737.
[17]JONES JP JR.Intravascular coagulation and osteonecrosis[J].Clinical orthopaedics and related research,1992,(277):41-53.
[18]HAN LAN,PENG DAIYIN,XU FAN,et al.Studies on anti-platelet activation effect and partial mechanisms of Taohong Siwu decoction[J].Zhongguo Zhong Yao Za Zhi,2010,35(19):2609-2612.
[19]蔡昫,卢敏.桃红四物汤对大白兔股骨干骨折术后血液流变学的影响[J].湖南中医杂志,2014,30(2):124-125.
[20]金翔,时乐,汪珊珊,等.桃红四物汤不同提取部位对血虚血瘀模型大鼠微循环的影响[J].安徽医药,2010,14(4):387-389.
[21]柳景红,刘登义,陈振中,等.桃红四物汤对急性深静脉血栓模型大鼠血清IL-6和TNF-α水平的影响[J].湖南中医药大学学报,2019,39(1):32-34.
[22]师宝森.加味桃红四物汤联合微创小切口人工全髋关节置换术治疗股骨头坏死的疗效[J].实用中医内科杂志,2021,35(8):54-56.
[23]LI WY,XIONG H.Effect of Taohong Siwu Decoction early intervention on mesenchymal stem cells homing in fracture healing in rats[J].Zhongguo Gu Shang,2022,35(4):367-374.
[24]唐晓璐.基于骨髓间充质干细胞迁移探讨桃红四物汤促进骨折愈合的实验研究[D].长沙:湖南中医药大学,2020.
[25]LU XL,LI J,ZHOU B,et al.Taohong Siwu Decoction enhances human bone marrow mesenchymal stem cells proliferation,migration and osteogenic differentiation via VEGF-FAK signaling in vitro[J].Journal of ethnopharmacology,2023,307:116203.
[26]余晓愉,熊辉,周钰健,等.桃红四物汤组方有效单体成分对早期骨折治疗的量效关系研究[J].中国中医急症,2021,30(4):595-599.
[27]吴智恒,吴睿哲,荣尚,等.基于BMP/Smads/Runx2信号通路探讨桃红四物汤对创伤性股骨头坏死模型大鼠成骨化表达和病理形态学的影响[J].中医药导报,2022,28(9):7-13.
[28]马文元.基于特异性转录因子Osterix探究桃红四物汤对大鼠创伤性股骨头坏死的影响[D].长沙:湖南中医药大学,2022.
[29]CHEN FF,WANG MM,XIA WW,et al.Tao-Hong-Si-Wu Decoction promotes angiogenesis after cerebral ischaemia in rats via platelet microparticles[J].Chinese journal of natural medicines,2020,18(8):620-627.
[30]吴磊磊,张俊忠.基于网络药理学的桃红四物汤治疗骨关节炎作用机制研究[J].现代中医药,2021,41(5):24-33.
[31]林行会,庄至坤,徐福东,等.加味桃红四物汤联合介入治疗成人Ficat 0-Ⅱ期股骨头缺血性坏死的疗效观察[J].中医临床研究,2019,11(23):89-92.
[32]王亚忠,李江.加味桃红四物汤联合介入治疗激素性股骨头坏死的临床观察[J].中国中医急症,2016,25(11):2198-2200.
[33]龙强.桃红四物汤加减治疗气滞血瘀型早期股骨头坏死临床观察[D].乌鲁木齐:新疆医科大学,2019.
[34]张秀伟.桃红四物汤对激素性股骨头缺血坏死局部微血管密度的影响[J].世界复合医学,2021,7(5):18-20.
[35]赵会晓.桃红四物汤联合针灸治疗早期非创伤性股骨头坏死47例临床观察[J].中国民族民间医药,2020,29(14):99-101.
[36]李翔.小针刀联合桃红四物汤治疗早中期股骨头坏死随机平行对照研究[J].实用中医内科杂志,2015,29(8):150-152.
[37]姚金龙,冯海波,孙绍裘.桃红四物汤治疗创伤性股骨头坏死临床疗效的观察[J].中国医药科学,2019,9(21):9-12,59.
基金项目:甘肃省自然科学基金项目(17JR5RA054,22JR5RA628)